https://doi.org/10.4081/bse.164
Targeting cancer drug resistance by modulation of ERCC1-XPF and p53 activity
Published: 29 September 2021
Abstract Views: 473
PDF: 265
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Authors
New disruptors of the ERCC1-XPF interaction interaction have a synergistic effect with traditional NER inhibitors, in p53 positive cells. Furthermore, the synergy can be resumed in p53 negative cells upon reactivation of the TP53 gene.
[1] Gentile, F, Elmenoufy, AH, Ciniero, G, et al. Computer-aided drug design of small molecule inhibitors of the ERCC1-XPF protein–protein interaction. Chem Biol Drug Des 2020;95:460– 71.
[2] Jordheim LP, Barakat KH, Heinrich-Balard L, et al. Small molecule inhibitors of ERCC1-XPF protein-protein interaction synergize alkylating agents in cancer cells. Mol Pharmacol 2013;84:12-24.
[3] Friboulet L, Soria JC, Olaussen KA. The “Guardian of the Genomeâ€â€”An Old Key to Unlock the ERCC1 Issue. Clin Cancer Res 2019;25:2369-71.
[4] Ciniero G, Elmenoufy AH, Gentile F, et al. Enhancing the activity of platinum-based drugs by improved inhibitors of ERCC1-XPF-mediated DNA repair. Cancer Chemother Pharmacol 2021;87:259-67.
[2] Jordheim LP, Barakat KH, Heinrich-Balard L, et al. Small molecule inhibitors of ERCC1-XPF protein-protein interaction synergize alkylating agents in cancer cells. Mol Pharmacol 2013;84:12-24.
[3] Friboulet L, Soria JC, Olaussen KA. The “Guardian of the Genomeâ€â€”An Old Key to Unlock the ERCC1 Issue. Clin Cancer Res 2019;25:2369-71.
[4] Ciniero G, Elmenoufy AH, Gentile F, et al. Enhancing the activity of platinum-based drugs by improved inhibitors of ERCC1-XPF-mediated DNA repair. Cancer Chemother Pharmacol 2021;87:259-67.
How to Cite
Ciniero, G., Gentile, F., Elmenoufy, A. H., Cros-Perrial, E. ., West, F. G., Weinfeld, M., … Tuszynski, J. A. (2021). Targeting cancer drug resistance by modulation of ERCC1-XPF and p53 activity. Biomedical Science and Engineering, 2(1). https://doi.org/10.4081/bse.164
PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.
Most read articles by the same author(s)
- Jack A. Tuszynski, Edward A. Rietman, How systems biology of cancer signaling pathways can inform optimized combination chemotherapy design , Biomedical Science and Engineering: Vol. 3 No. 1 (2022)
- Gianvito Grasso, Lorenzo Pallante, Jack A. Tuszynski, Umberto Morbiducci, Marco A. Deriu, Computational molecular modelling as a platform for a deeper understanding of protein dynamics and rational drug design , Biomedical Science and Engineering: Vol. 1 No. 1 (2020)
- Michela Sperti, Fabrizio D'Ascenzo, Luca Navarini, Giacomo Di Benedetto, Antonella Afeltra, Roberto Giacomelli, Marco A. Deriu, Machine learning approaches as an alternative to traditional statistical methods in cardiovascular risk prediction , Biomedical Science and Engineering: Vol. 2 No. 1 (2021)
- Marcello Miceli, Cecile Exertier, Beatrice Vallone, Marco Cavaglià, Marco A. Deriu, Elucidating molecular connection between IAHSP onset and Alsin protein by means of homology modelling and molecular dynamics , Biomedical Science and Engineering: Vol. 2 No. 1 (2021)
- Eric A. Zizzi, Marco Cavaglià, Marco A. Deriu, Jack A. Tuszynski, In silico investigation of molecular interactions of volatile anesthetics: effects on phospholipid membranes and subcellular targets , Biomedical Science and Engineering: Vol. 2 No. 1 (2021)
Similar Articles
- Jack A. Tuszynski, Edward A. Rietman, How systems biology of cancer signaling pathways can inform optimized combination chemotherapy design , Biomedical Science and Engineering: Vol. 3 No. 1 (2022)
- Alessio Malacrida, Mirko Rivara, Omar Ben Mariem, Alessandro Di Domizio, Giacomo Cislaghi, Mariarosaria Miloso, Valentina Zuliani, Gabriella Nicolini, Innovative 3D proteome-wide scale identification of ALKBH5 target for MV1035 small molecule able to reduce migration and invasiveness in U87 glioblastoma cell lines by SPILLO-PBSS , Biomedical Science and Engineering: Vol. 2 No. 1 (2021)
- Susi Burgalassi, Erica Zucchetti, Eleonora Terreni, Daniela Monti, Silvia Tampucci, Patrizia Chetoni, Reconstituted epithelial corneal tissues for evaluation of drug delivery , Biomedical Science and Engineering: Vol. 1 No. 1 (2020)
- Stefania Forciniti, Marta Cavo, Ilaria Dando, Elisa Dalla Pozza, Marta Palmieri, Loretta L. del Mercato, Promising 3D in vitro models for studying tumour heterogeneity and testing novel therapeutic approaches in pancreatic cancer , Biomedical Science and Engineering: Vol. 2 No. 1 (2021)
- Désirée Baruffaldi, Marta Canta, Candido Fabrizio Pirri, Francesca Frascella, Development of in vitro 3D culture system to mimic lung cancer tissue , Biomedical Science and Engineering: Vol. 2 No. 1 (2021)
- Massimiliano Runfola, Michele Perni, Simona Sestito, Grazia Chiellini, Michele Vendruscolo, Simona Rapposelli, SG-2: A promising lipolytic and pro-autophagic hit-compound to treat Alzheimer's disease , Biomedical Science and Engineering: Vol. 1 No. 1 (2020)
- Danila Cianciosi, Lucia Regolo, Maurizio Battino, Francesca Giampieri, Effect of manuka honey on 5-fluorouracil chemosensitivity in colonspheres enriched with cancer stem (-like) cells , Biomedical Science and Engineering: Vol. 2 No. 1 (2021)
- Paola Occhetta, Roberta Visone, Stefano Piazza, Ferran Lozano, Marco Rasponi, Beating organs-on-chip as technological platforms in drug screening: advanced in vitro models of human physiology and pathology , Biomedical Science and Engineering: Vol. 3 No. 1 (2022)
- Gianvito Grasso, Lorenzo Pallante, Jack A. Tuszynski, Umberto Morbiducci, Marco A. Deriu, Computational molecular modelling as a platform for a deeper understanding of protein dynamics and rational drug design , Biomedical Science and Engineering: Vol. 1 No. 1 (2020)
- Ryan Conder, Leon H. Chew, Fisal Elstone, Marianne Lankhorst, Adam Añonuevo, Salvatore Simmini, Wing Chang, Allen C. Eaves, Terry E. Thomas, Sharon A. Louis, Organoid culture systems: Products supporting one of the biggest revolutions in biological research , Biomedical Science and Engineering: Vol. 1 No. 1 (2020)
You may also start an advanced similarity search for this article.
